Latest KRBP reports update at 2023-11-14: 2023-Q32022-Q42022-Q3
Kiromic BioPharma logo

Kiromic BioPharma KRBP

$ 3.15 6.61%

Country

usaUSA

IPO year

2020

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Maurizio Chiriva Internati Ph.D.

Employees in the company

11

Shares

544 K

Market Cap[1]

$ 3.08 M

EBITDA (LTM)

$ -20.8 M

P/E (LTM)

-0.09

P/S (LTM)

-

EPS (LTM)

-33.54

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.